Cystic Fibrosis: all 1,605 studies

Page 16 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung DiseaseCompletedNCT00357279Phase 3
• Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled AirTerminatedNCT00356629
• PTC124 for the Treatment of Cystic FibrosisCompletedNCT00351078Phase 2
• Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung TransplantationCompletedNCT00345449Not applicable
• Ocular Surface Changes in Patients With Cystic FibrosisStatus unknownNCT00345280
• Capsule Endoscopy in Cystic FibrosisCompletedNCT00333957
• Continuous Versus Short Infusions of Ceftazidime in Cystic FibrosisTerminatedNCT00333385Phase 4
• A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.TerminatedNCT00332215Phase 1
• Rare Genetic Disorders of the Breathing AirwaysCompletedNCT00323167
• Hydroxychloroquine in Cystic FibrosisCompletedNCT00311883Phase 1
• A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung DiseaseCompletedNCT00311506
• Involvement of Endogenous Digitalis-like Compounds in Breast CancerWithdrawnNCT00310882
• Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic FibrosisCompletedNCT00308958Not applicable
• Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.CompletedNCT00308243Phase 1
• Azithromycin in Patients With CF, Infected With Burkholderia Cepacia ComplexStatus unknownNCT00298922Phase 2
• Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.WithdrawnNCT00287456Not applicable
• Metabolic Abnormalities in Hispanic Children With Cystic FibrosisWithdrawnNCT00287443Not applicable
• Growth Hormone Use in Adolescents and Adults With Cystic FibrosisWithdrawnNCT00287430Not applicable
• Efficacy of Amiloride and Hypertonic Saline in Cystic FibrosisCompletedNCT00274391Phase 2
• Safety Study of Inhaled 552-02 in Cystic Fibrosis PatientsCompletedNCT00274313Phase 1/2
• The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic FibrosisCompletedNCT00271310Phase 3
• Prevalence of Chronic Rhinosinusitis in Cystic FibrosisCompletedNCT00266474
• Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic RhinosinusitisCompletedNCT00265434Phase 3
• Growth Hormone Treatment Study in Children With Cystic FibrosisWithdrawnNCT00256555Phase 2/3
• Effect of Simvastatin on CF Airway InflammationCompletedNCT00255242Phase 1
• Mannitol Dose Response Study in Cystic FibrosisCompletedNCT00251056Phase 2
• Assessing Mucociliary Clearance and Airway Liquid Volume in the CF AirwayCompletedNCT00248755Not applicable
• Cystic Fibrosis and Totally Implantable Vascular Access DevicesCompletedNCT00244270Phase 4
• Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast PainStatus unknownNCT00237523Phase 3
• Safety and Efficacy of Ataluren (PTC124) for Cystic FibrosisCompletedNCT00237380Phase 2
• PTC124 for Cystic FibrosisCompletedNCT00234663Phase 2
• Effects of a 6-Months Physical Conditioning Program in Patients With Cystic FibrosisCompletedNCT00231686Phase 2/3
• Repaglinide for Adolescents With Cystic Fibrosis-Related DiabetesWithdrawnNCT00231192Not applicable
• Insulin Glargine Vs Standard Insulin TherapyCompletedNCT00222521Phase 3
• The Microvascular Complications StudyCompletedNCT00222508
• Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic FibrosisCompletedNCT00221572
• Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control GroupCompletedNCT00221559
• Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic FibrosisCompletedNCT00221546Phase 2
• Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)CompletedNCT00220259Not applicable
• Assessment of Inflammatory Mediators (AIM)CompletedNCT00219895Not applicable
• Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic FibrosisCompletedNCT00219882Phase 1
• An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat MalabsorptionCompletedNCT00217204Phase 2
• Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.TerminatedNCT00208078Phase 4
• Macrolide Antibiotic Therapy for Patients With Cystic FibrosisCompletedNCT00205634Phase 2
• Mucin in Sputum of CF During Pulmonary ExacerbationStatus unknownNCT00202072
• Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their LungsCompletedNCT00198289Phase 2
• An Interactive Program to Improve Care for Children With CFCompletedNCT00185549Not applicable
• Inhaled Bicarbonate Therapy in Cystic FibrosisCompletedNCT00177645Phase 1
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseCompletedNCT00164138Not applicable
• The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung TransplantationStatus unknownNCT00164021
• Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic FibrosisStatus unknownNCT00163852Phase 2/3
• Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory DiseaseStatus unknownNCT00163696
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis PatientsCompletedNCT00157690Phase 4
• Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen DesaturationCompletedNCT00157183Phase 1/2
• Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)CompletedNCT00153634Not applicable
• A Study in Pediatric Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00130182Phase 2
• Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary RehabilitationStatus unknownNCT00129350Phase 1
• Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis SubjectsTerminatedNCT00125346Phase 3
• Comparison of Inhaled Mannitol and rhDNase in Children With Cystic FibrosisCompletedNCT00117208Phase 2
• Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)CompletedNCT00104494Not applicable
• Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00103714Phase 2
• Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic InsufficiencyCompletedNCT00095732Phase 2
• Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)CompletedNCT00082238Not applicable
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic FibrosisCompletedNCT00079742Phase 2
• Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic FibrosisTerminatedNCT00073463Phase 2/3
• Diabetes Therapy to Improve BMI and Lung Function in CFCompletedNCT00072904Phase 3
• Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric PatientsTerminatedNCT00060801Phase 2
• Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung DiseaseCompletedNCT00056147Phase 2
• Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic FibrosisCompletedNCT00043342Phase 1/2
• Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic FibrosisCompletedNCT00043316Phase 1/2
• The Role of Bacteria and Genetic Variations in Cystic FibrosisCompletedNCT00043225
• Genetic Modifiers of Cystic Fibrosis: Sibling StudyCompletedNCT00037778
• Gene Modifiers of Cystic Fibrosis Lung DiseaseActive, not recruitingNCT00037765
• A Study in Adult and Pediatric Patients With Cystic FibrosisCompletedNCT00034515Phase 1/2
• Role of Toxins in Lung Infections Caused by Pseudomonas AeruginosaCompletedNCT00027183
• Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET ImagingStatus unknownNCT00023465
• Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)CompletedNCT00016744Phase 1/2
• Phase II Study of Growth Hormone in Children With Cystic FibrosisCompletedNCT00016445Phase 2
• Tissue Collection From People With Cystic FibrosisCompletedNCT00015756
• Benefits and Risks of Newborn Screening for Cystic FibrosisCompletedNCT00014950Not applicable
• Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic FibrosisCompletedNCT00014781
• Study of Metabolic Effects of Pregnancy in Women With Cystic FibrosisTerminatedNCT00014768
• Pressure Support Ventilation During CF ExacerbationsSuspendedNCT00008775Not applicable
• Bone Health of People With Cystic FibrosisCompletedNCT00008762
• A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic FibrosisCompletedNCT00006280Phase 2
• Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic FibrosisStatus unknownNCT00006273
• Behavioral Treatment of Weight Gain in CFCompletedNCT00006169Phase 3
• Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic FibrosisCompletedNCT00006063Not applicable
• Growth Hormone Use in Cystic Fibrosis - a Multicenter StudyCompletedNCT00005112Phase 3
• A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic FibrosisSuspendedNCT00005110Not applicable
• Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic FibrosisCompletedNCT00004829Phase 3
• Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic FibrosisCompletedNCT00004806Phase 1
• Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic FibrosisCompletedNCT00004779Phase 1
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic FibrosisCompletedNCT00004747Phase 2
• Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic FibrosisCompletedNCT00004705Not applicable
• Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic FibrosisCompletedNCT00004533Phase 1
• Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related OsteoporosisCompletedNCT00004489Not applicable
• Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene TransferCompletedNCT00004471Phase 1
• Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic FibrosisCompletedNCT00004441Not applicable
• Study of Ibuprofen to Preserve Lung Function in Patients With Cystic FibrosisCompletedNCT00004440Not applicable

← Cystic Fibrosis overview